Immunohematology - Medical Devices Pipeline Assessment, 2019
Summary
The Publisher's Medical Devices sector report, “Immunohematology - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunohematology currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunohematology pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to Buy
The report enables you to:
Summary
The Publisher's Medical Devices sector report, “Immunohematology - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunohematology currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunohematology pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the Publisher's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Immunohematology under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Immunohematology and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Immunohematology under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
1.1 List of Tables1.2 List of Figures
2 Introduction
2.1 Immunohematology Overview
3 Products under Development
3.1 Immunohematology - Pipeline Products by Stage of Development
3.2 Immunohematology - Pipeline Products by Segment
3.3 Immunohematology - Pipeline Products by Territory
3.4 Immunohematology - Pipeline Products by Regulatory Path
3.5 Immunohematology - Pipeline Products by Estimated Approval Date
4 Immunohematology - Pipeline Products under Development by Companies
4.1 Immunohematology Companies - Pipeline Products by Stage of Development
4.2 Immunohematology - Pipeline Products by Stage of Development
5 Immunohematology Companies and Product Overview
5.1 AbSorber AB Company Overview
5.1.1 AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
5.2 Alba Bioscience Limited Company Overview
5.2.1 Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
5.3 Amity University Company Overview
5.3.1 Amity University Pipeline Products & Ongoing Clinical Trials Overview
5.4 Arizona State University Company Overview
5.4.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
5.5 Biofortuna Ltd Company Overview
5.5.1 Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.6 Grifols SA Company Overview
5.6.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
5.7 Ortho-Clinical Diagnostics Inc Company Overview
5.7.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.8 Quotient Ltd Company Overview
5.8.1 Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Transfusion & Transplantation Technologies (Inactive) Company Overview
5.9.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6 Immunohematology- Recent Developments
6.1 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results
6.2 Nov 01, 2019: Haemonetics reports 2nd quarter and 1st half fiscal 2020 results; raises fiscal 2020 adjusted operating margin and adjusted EPS guidance
6.3 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results
6.4 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.
6.5 Oct 14, 2019: Biocare Medical appoints Nicolas Barthelemy as Executive Chairman
6.6 Sep 24, 2019: Theradiag announces improved results for H1 2019
6.7 Sep 12, 2019: Haemonetics Appoints Stewart W. Strong As President, Global Hospital
6.8 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement
6.9 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
6.10 Aug 06, 2019: Haemonetics reports 1st Quarter Fiscal 2020 results, updates Fiscal 2020 earnings guidance and launches operational excellence program
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Immunohematology - Pipeline Products by Stage of Development
Table 2: Immunohematology - Pipeline Products by Segment
Table 3: Immunohematology - Pipeline Products by Territory
Table 4: Immunohematology - Pipeline Products by Regulatory Path
Table 5: Immunohematology - Pipeline Products by Estimated Approval Date
Table 6: Immunohematology Companies - Pipeline Products by Stage of Development
Table 7: Immunohematology - Pipeline Products by Stage of Development
Table 8: AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ABO Diagnostic Test - Product Status
Table 10: ABO Diagnostic Test - Product Description
Table 11: Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 12: ALBAcyte O Adult i Cell Reagent - Product Status
Table 13: ALBAcyte O Adult i Cell Reagent - Product Description
Table 14: ALBAcyte O RhD VI Reagent Cells - Product Status
Table 15: ALBAcyte O RhD VI Reagent Cells - Product Description
Table 16: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Blood Group Testing Kit - Product Status
Table 18: Blood Group Testing Kit - Product Description
Table 19: Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Blood Screening Immunosignaturing - Product Status
Table 21: Blood Screening Immunosignaturing - Product Description
Table 22: Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: HemoPlex Kell Genotyping Kit - Product Status
Table 24: HemoPlex Kell Genotyping Kit - Product Description
Table 25: HemoPlex Kidd & Duffy Genotyping Kit - Product Status
Table 26: HemoPlex Kidd & Duffy Genotyping Kit - Product Description
Table 27: HemoPlex MNS Genotyping Kit - Product Status
Table 28: HemoPlex MNS Genotyping Kit - Product Description
Table 29: HemoPlex Multi Blood Group Genotyping Kit - Product Status
Table 30: HemoPlex Multi Blood Group Genotyping Kit - Product Description
Table 31: HemoPlex RHCE Screening Kit - Product Status
Table 32: HemoPlex RHCE Screening Kit - Product Description
Table 33: HemoPlex RHCE Variant Genotyping Kit - Product Status
Table 34: HemoPlex RHCE Variant Genotyping Kit - Product Description
Table 35: HemoPlex RHD & CE Genotyping Kit - Product Status
Table 36: HemoPlex RHD & CE Genotyping Kit - Product Description
Table 37: HemoPlex RHD Variant Genotyping Kit - Product Status
Table 38: HemoPlex RHD Variant Genotyping Kit - Product Description
Table 39: ThromboPlex HPA Screening Kit - Product Status
Table 40: ThromboPlex HPA Screening Kit - Product Description
Table 41: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
Table 42: IH Blood Genotyping (D) Kit - Product Status
Table 43: IH Blood Genotyping (D) Kit - Product Description
Table 44: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: ORTHO AutoVue - Rare Sera Assay - Product Status
Table 46: ORTHO AutoVue - Rare Sera Assay - Product Description
Table 47: ORTHO BioVue - Rare Sera Assay - Product Status
Table 48: ORTHO BioVue - Rare Sera Assay - Product Description
Table 49: Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Eluate Kit - Product Status
Table 51: Eluate Kit - Product Description
Table 52: Expanded IH Microarray - Product Status
Table 53: Expanded IH Microarray - Product Description
Table 54: IH Microarray Patient - Product Status
Table 55: IH Microarray Patient - Product Description
Table 56: Polyagglutionation Kit - Product Status
Table 57: Polyagglutionation Kit - Product Description
Table 58: Sensitivity Kit Anti-S, K, e, C - Product Status
Table 59: Sensitivity Kit Anti-S, K, e, C - Product Description
Table 60: Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Immunohematology - Pipeline Products by Stage of Development
Figure 2: Immunohematology - Pipeline Products by Segment
Figure 3: Immunohematology - Pipeline Products by Territory
Figure 4: Immunohematology - Pipeline Products by Regulatory Path
Figure 5: Immunohematology - Pipeline Products by Estimated Approval Date
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbSorber AB
- Alba Bioscience Limited
- Amity University
- Arizona State University
- Biofortuna Ltd
- Grifols SA
- Ortho-Clinical Diagnostics Inc
- Quotient Ltd
